Safety and efficacy of angiotensin II receptor antagonists
- 作者Joel M Neutel
- 卷第84卷
- 印刷ISSN0002-9149
- 文件大小159.03KB
- 发表时间1999
- DOI10.1016/s0002-9149(99)00401-4
- 页码13-17
同作者推荐
The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish populationPertti Jääskeläinen; Marja Soranta; Raija Miettinen; Laura Saarinen; Jussi Pihlajamäki; Karoliina Silvennoinen; Tero Tikanoja; Markku Laakso; Johanna Kuusisto · 1998
Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy–causing mutations in the β-myosin heavy chain, α-tropomyosin, and myosin-binding protein C genesTuija Poutanen; Tero Tikanoja; Pertti Jääskeläinen; Eero Jokinen; Annuli Silvast; Markku Laakso; Johanna Kuusisto · 2006